Unionkorea Pharm Co (XKRX:080720) Total Liabilities : ₩66,651 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unionkorea Pharm Co Total Liabilities?

Unionkorea Pharm Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩66,651 Mil.

Unionkorea Pharm Co's quarterly Total Liabilities declined from Jun. 2024 (₩68,810.61 Mil) to Sep. 2024 (₩65,667.47 Mil) but then increased from Sep. 2024 (₩65,667.47 Mil) to Dec. 2024 (₩66,650.86 Mil).

Unionkorea Pharm Co's annual Total Liabilities increased from Dec. 2022 (₩63,910.48 Mil) to Dec. 2023 (₩64,101.32 Mil) and increased from Dec. 2023 (₩64,101.32 Mil) to Dec. 2024 (₩66,650.86 Mil).

Unionkorea Pharm Co Total Liabilities Historical Data

The historical data trend for Unionkorea Pharm Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unionkorea Pharm Co Total Liabilities Chart

Unionkorea Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

28,814.04

66,703.09

63,910.48

64,101.32

66,650.86

Unionkorea Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															64,101.32	62,840.23	68,810.61	65,667.47	66,650.86

Unionkorea Pharm Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Unionkorea Pharm Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	63949.417	+	(230.989	+	267.49899999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	2163.776	+	39.174)
	=	66,651

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	74900.211	-	8249.356
	=	66,651

Unionkorea Pharm Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	63949.417	+	(230.989	+	267.49899999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	2163.776	+	39.174)
	=	66,651

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	74900.211	-	8249.356
	=	66,651

Unionkorea Pharm Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Unionkorea Pharm Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Unionkorea Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unionkorea Pharm Co Ltd (XKRX:080720) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

4th Floor, 417, Samwhan-HIPEX A Tower B/D 240, Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 13493

Website

http://www.ukp.co.kr

Unionkorea Pharm Co Ltd is a pharmaceutical company. The company is engaged in the development, manufacturing and marketing of brain metabolism enhancer, prescription drugs, Anti-inflammatory analgesics, and skeletal muscle relaxants.

Unionkorea Pharm Co Headlines

No Headlines